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Introduction
Fever is one of the most common clinical manifes-
tations referred by patients to their physicians (1).
The challenge is to distinguish between fevers
caused by the more or less serious pathologies,
requiring a specific therapy, and those caused by
the vast majority of other ailments, which instead
often present a self-limited pathology. Fever is
defined as an increase in body temperature medi-
ated by a functional alteration of the regulatory
centre of the hypothalamus, causing a rise in tem-
perature towards the upper values of the set-point,
the activation of the peripheral mechanisms of
thermogenesis and the inhibition of those of ther-
modispersion (2,3). Hyperthermia, on the contrary,
is an increase in body temperature independent of
the physiological homeostatic control mechanisms,
which do not, however, raise the hypothalamus set-
point. In other words, it arises from a ‘peripheral’
alteration of the mechanisms of thermoproduction
and thermodispersion.
Another important condition is the fever of
unknown origin (FUO), which poses considerable
problems for physicians, because although most dis-
eases underlying FUO are treatable, they can be diffi-
cult to diagnose in a particular patient and for
reasons which are not always clear (4–11).
Low-grade fever (LGF) commonly refers to a con-
dition with a body temperature continually or inter-
mittently between 37.5 and 38.3 C. As in the case of
fever, it is absolutely a symptom accompanying very
many infectious, and autoimmune and neoplastic
diseases. Sometimes, however, there is no particular
organic pathology, as in the case of habitual hyper-
thermia (HH), which, rather than a disease, should
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What’s known
In the literature reviews focused on low grade fever
do not exist. There are only case report or cohort
studies which indicate exceptional cases that do
not reflect the overall epidemiological picture.
Moreover, from these studies, it is not always
possible to establish what the authors mean with
low grade fever, nor the method used to measure
it, nor the duration of the low grade fever, and the
papers analysed deal only with organic low grade
fevers and not with habitual hyperthermia.
What’s new
This is the only study which tries to better define
the habitual hyperthermia putting it in the sphere
of low grade fevers rather than in the fever in
general. To facilitate this study, we propose a
flow-chart of simple execution, easy feasibility and
excellent performance. On the contrary, we state
that organic low grade fevers always have to be
studied as FUO.
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be considered a paraphysiological variant of normal
body temperature (6).
Habitual hyperthermia is a clinical condition char-
acterised by a body temperature never higher than
38.3 C, with an erratic circadian rhythm. It may
persist for years and for rather complex reasons, and
the normal body temperature of an otherwise per-
fectly healthy subject remains elevated. It is typical of
young asthenic women prone to headaches and with
vasomotor liability. Its diagnosis today is still possi-
ble, but only after an adequately prolonged period of
observation and measurement of body temperature
(6). Although FUO is widely recognised and is fre-
quently reported, in our opinion, LGF has not
received adequate attention in the literature. This
work, therefore, reviews our clinical experience of
patients with LGF, with the aim of shedding further
light on its frequency, causes, management, work-up,
prognosis and possible links with the much better-
known forms of FUO.
Patients and methods
Our study group included all the cases referred for
LGF between 1997 and 2008 as outpatients at our
Department of Clinical Medicine, Policlinico Hospi-
tal, which is a tertiary referral centre.
Inclusion criteria were patients with axillary body
temperature continually or intermittently between
37.5 and 38.3 C for at least 3 weeks. Patients with
axillary body temperature ‡ 38.3 C at any time were
considered to be classical FUO and, therefore,
excluded. Patients who presented with LGF with par-
ticular symptoms or alarm signs (such as dysphagia,
rectorrhagia, severe weight loss, neurological disor-
ders, etc.), suggesting a serious organic disease were
also excluded.
We used the same classification that is generally
adopted for FUO, distinguishing between the classi-
cal diseases (infectious disease, neoplasm, inflamma-
tory non-infectious disease) and diseases that are
not easily classifiable (miscellaneous). In patients
diagnosed with LGF, we also investigated for HH, a
paraphysiological condition not associated with any
organic disease (6).
The first diagnostic step was a detailed anamnestic
investigation and thorough physical examination. The
patients’ axillary temperatures were then measured
and they were asked to measure it in the same manner
four times a day and to record results for 5 days in a
special booklet. When the anamnestic and physical
examination data indicated a strong hypothesis of
organic LGF, further appropriate biochemical and
instrumental tests were performed. If history was not
indicative and ⁄or physical examination was negative,
a strong hypothesis of HH was made. In this case,
only total blood cell count, erythrocyte sedimentation
rate, C-reactive protein (CRP) and urine analysis were
performed. If these were positive, clinical investiga-
tions continued with other examinations, otherwise a
bi-monthly follow up for 2 years in the same manner
and a continual monitoring of temperature were
scheduled.
Statistical analysis was performed using Student’s
t-test, the chi-square test and the Fisher exact test,
wherever appropriate. The diagnostic reliability of
organic LGF was evaluated by calculating sensitivity,
specificity, positive predictive value and negative pre-
dictive value, using standard formulas. p < 0.05 was
considered significant.
Results
Eighty-two patients were selected and, on the basis
of the final diagnosis, divided into two groups: group
A included 32 patients (14 men, 18 women) with
organic LGF, and group B included 50 subjects with
HH. In the latter group, however, five subjects were
excluded because they did not complete the planned
follow up, and after telephone invitations to
attend proved unsuccessful, they were considered to
have dropped out. Forty-five patients (16 men, 29
women) were therefore eventually included in this
group.
Aetiology of organic LGF (group A) is shown in
Table 1. In 19 out of 32 patients (59%), it was
because of underlying infectious disease; one patient
(3.1%) had neoplasm, two (6.2%) had inflammatory
non-infectious disease and six (18.7%) had miscella-
neous causes. In four patients (12.5%), there was no
definite diagnosis for organic LGF (undiagnosed
LGF): biochemical tests showed only aspecific
changes, imaging procedures were not diagnostic,
and in any case the fever disappeared within
4 months.
Diagnosis of HH was hypothesised after the first
evaluation, including history and physical examina-
tion, in 45 ⁄ 77 patients (58.5%). In four patients,
however, the initial diagnosis was not confirmed and
in the following 6 months these diagnoses were
made: one intestinal bacterial contamination in a
patient with dietary intolerance; one dental granu-
loma and one appendicitis with histological features
of Crohn’s disease; in the fourth case, sinusitis in a
subject allergic to pollen with rhinitis was diagnosed
after 12 months. A definitive diagnosis of HH was
therefore made in 41 out of 77 patients after 2 years
of follow up.
Mean age was significantly higher in the organic
LGF group A than in the HH group B (34 ± 14 vs.
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27 ± 9.2 years, p < 0.02). Within group B, age was
significantly higher in men than women (31 ± 8.5 vs.
24 ± 5.5 years, p < 0.05); this difference was also
present in group A, but it was not significant
(36.7 ± 14 vs. 31.7 ± 14 years; p = ns).
Table 2 shows the symptoms referred by the two
groups. Dizziness and a not well-defined general
malaise were the symptoms significantly associated
in group B. Loss of weight, on the contrary, was
significantly associated to organic LGF (group A)
(p < 0.05).
Table 3 shows the anomalies found at physical
examination. Lack of any pathological signs at physi-
cal examination was more frequent in subjects with
HH (p < 0.0001), while the rate of splenomegaly and
weight loss were significantly greater in group A
(p < 0.03 and p < 0.05 respectively).
Among the biochemical tests, white blood cells
and CRP showed a higher number of elevated values
in group A than in group B [10 ⁄ 32 vs. 1 ⁄ 41
(p < 0.05) and 9 ⁄ 32 vs. 1 ⁄ 41 (p < 0.05) respec-
tively]. No difference was found between the two
Table 1 Final diagnosis of patients with low-grade fever (LGF), diagnostic tools and hypothesised diagnosis at first
evaluation
Diagnosis Patients n (%) Diagnostic tools First evaluation
Mononucleosis 4 (12.5) Serology Organic LGF
Brucellosis 6 (18.8) Serology Organic LGF
Autoimmune thyroiditis 2 (6.3) Autoantibodies ⁄ ultrasound scan Organic LGF
Toxoplasmosis 2 (6.3) Serology Organic LGF
Cat-scratch disease 1 (3.1) Serology Organic LGF
Sinusitis 1 (3.1) Radiography Habitual hypertermia
Pulmonary actinomycosis 1 (3.1) Histology Organic LGF
Bacterial endocarditis 2 (6.2) Transesophageal echocardiography Organic LGF
Undiagnosed LGF 4 (12.5) * Organic LGF
Systemic lupus erythematosus 1 (3.2) Autoantibodies Organic LGF
Crohn’s disease 2 (6.2) Histology Organic LGF
Ehlers-Danlos syndrome with diverticulitis 1 (3.1) Colonoscopy Organic LGF
Rheumatoid arthritis 1 (3.1) Signs and symptoms ⁄ rheumatoid factor Organic LGF
Food intolerance with bacterial overgrowth 1 (3.1) Breath test Habitual hypertermia
Dental granuloma 1 (3.1) Orthopantomography Habitual hypertermia
Appendicitis 1 (3.1) Surgery Habitual hypertermia
NH lymphoma 1 (3.1) Histology Organic LGF
*Serological and instrumental tests negative.
Table 2 Referred symptoms of patients with organic
LGF (group A) and habitual hyperthermia (group B)
Symptoms
Group A
n = 32
Group B
n = 41 p
Nausea 1 5 ns
Anorexia 1 5 ns
Arthralgia 8 4 ns
Headache 5 2 ns
Cough 3 2 ns
Chills 3 0 ns
Asthenia 3 6 ns
Abdominal pain 5 4 ns
Sore throat 4 3 ns
Sweating 3 0 ns
Dizziness 0 7 0.02
Pruritus 0 2 ns
Intercostal pain 0 2 ns
Not defined general malaise 0 15 0.0001
Weight loss 9 1 0.05
Table 3 Presence of signs at physical examination in
the two groups of patients
Signs
Group A
n = 32
Group B
n = 41 p
No signs 2 30 0.0001
Lymphadenopathy 14 9 ns
Hepatomegaly 3 4 ns
Splenomegaly 6 0 0.03
Pharyngeal inflammation 3 0 ns
Skin lesions 1 0 ns
Cardiac murmur 3 0 ns
Pain on abdomen
palpation
8 4 ns
Group A: organic LGF and group B: habitual hyperthermia.
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groups for erythrocyte sedimentation rate (ESR) and
urine analysis. None of the 41 subjects with a final
diagnosis of HH, however, showed particular altera-
tions in biochemical parameters in the follow-up
period; therefore, the alterations found in two
patients at commencement of the study could have
been because of seasonal viruses.
Thirty-two of the 41 subjects with HH who com-
pleted the 24 months of follow up had stopped mea-
suring their body temperatures and defined their
general health condition as good. At the first step,
our diagnostic evaluation incorrectly classified four
subjects as HH (false positive), thus having 91% sen-
sitivity and 87% specificity. After 6 months, diagno-
sis of HH was hypothesised in 42 patients, with only
one patient still incorrectly labelled as HH, therefore
with 97% sensitivity and specificity and 97% post-
test probability of HH (Table 4). Consequently, on
the basis of these results, we propose a diagnostic
algorithm (Figure 1), which is easy to apply and is
also highly efficient for outpatients, but obviously
needs to be confirmed by further studies.
Discussion
Fever of unknown origin is a well-defined entity with
three classical diagnostic criteria, as first established
by Petersdorf and Beeson: (i) illness of more than
3 weeks’ duration, (ii) with a temperature higher
than 38.3 C on several occasions and (iii) no estab-
lished diagnosis after 1 week of evaluation (4). Thirty
years later, Durack and Street proposed a reduction
in the third criterion from 1 week to 3 days of
appropriate investigations, because of the progress in
diagnostic techniques (12). The other two criteria
have remained unchanged. However, the second cri-
terion (fever > 38.3 C) excludes a series of fevers
below 38.3 C, which must nevertheless be recogni-
sed to avoid discomfort to patients and prevent
waste of public money, as they present a clinical
course and pose diagnostic difficulties similar to
those of FUO. In this report, we refer our experience
of patients suffering from fever below 38.3 C and
propose an algorithm to facilitate a correct diagnosis.
Our results, in contrast with the few epidemio-
logical data in the literature (4,5,12), show that the
prevalence of HH is higher (54%) than LGF from
Table 4 Discrimination of habitual hyperthermia from
organic low-grade fever (LGF) at first evaluation (panel
A) and after 6 months of follow up (panel B)
Habitual
hyperthermia
Organic
LGF
Panel A
Correct diagnosis 41 28
Incorrect diagnosis 4 0
Panel B
Correct diagnosis 41 31
Incorrect diagnosis 1 0
Sensitivity 97%; specificity 97%; positive post-test probability
97%, sensitivity 91%; specificity 88%.
Figure 1 Algorithm for the diagnostic definition of low-grade fever
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organic causes (46%). In the work of Knockaert et al.
the prevalence of HH among FUO was as low as
2.5% (13). There may be various reasons for this dif-
ference:
• It could be because of a selection bias. Ours is a
tertiary referral centre for fever pathologies and we
are probably asked to investigate fevers for which
no solution has been found in spite of the patient
being followed for a long time by general practitio-
ners or in non-specialised centres. HH may there-
fore be more difficult to evaluate than organic
LGF;
• In the literature, HH is not always correctly
defined and it is often mistakenly included with
FUO, which, by definition, refers to patients with a
body temperature ‡ 38.3 C, while HH ‡ 38.3 C is
an exceptional event. In this category of patients,
HH may thus have only a marginal epidemiological
role.
In our study, the HH subjects were prevalently
woman, although this result was not statistically sig-
nificant. Little is known about the causes of this
higher frequency, already reported in the literature
(6). Clinical history in HH, in contrast with organic
LGF, shows little of note: there is a prevalent symp-
tomatology of cenesthopathy, dizziness and a not
well-defined state of general malaise, which may also
be correlated to a state of anxiety or depression as a
consequence of the hyperthermia of unclear origin,
as reported by Reimann (14). In contrast, weight loss
is significantly associated with the organic forms. In
this respect, it should be remembered that the above
psychological states sometimes associated with HH
should be investigated and evaluated because they
could also lead to weight loss. In these cases, it may
be useful to investigate for signs of weight loss and
malnutrition during physical examination and in the
laboratory tests.
Physical examination in our study population was
negative in 73% of the HH patients compared with
6.2% in organic LGF, and the few clinical signs pres-
ent in HH (for example lymphadenopathy and hepa-
tomegaly), may be aspecific and misleading. Finally,
simple and easily performable laboratory assays, such
as total blood cell count and CRP were altered, with
a higher frequency in organic LGF.
It should also be underlined that, as happens in
FUO, a certain percentage of forms remain undiag-
nosed in LGF, in our study population 12.5%. These
forms can be distinguished by the initial presence of
laboratory alterations, which however, rapidly nor-
malise with the disappearance of the LGF. Precisely,
this difference in temperature evolution – a normali-
sation in organic LGF with unknown aetiology
compared with a persistent fever in HH – suggests
that HH in LGF may be simply interpreted as an
adjustment of the hypothalamus set-point towards
higher values, and therefore considered a paraphysio-
logical variant rather than a pathological condition.
It may simply be one of the two extremities of the
Gaussian distribution of human body temperature:
the higher one.
In the light of the data we obtained, it is impor-
tant to underline two aspects:
• a prolonged follow up, as mentioned above, repre-
sents the only valid diagnostic tool to exclude
organic pathologies in patients with LGF;
• the diagnostic approach of our study, from which
we deduced the above-mentioned algorithm, presents
a 97% probability of diagnosis of HH at 6 months.
This would allow us to already reassure the patient
during the first few visits. Only by doing so can we
prevent the hypochondriac delirium, which leads a
patient to become thermometer-dependent and to
construct a host of more or less complex symptoms,
building up a clinical picture, which at that point is
difficult to diagnose and at times can only really be
cured by a psychiatrist.
As regards organic LGF, the small number of
cases in our population did not allow us to reach
any definitive conclusions, and as mentioned above
it is difficult to compare our results because of the
very few reports in the literature. What emerges is
that, as in the majority of cases of FUO, the most
frequent cause was infection followed by miscella-
neous causes. This would confirm the emerging
role of inflammatory non-infectious disease, which
is being more frequently reported in the various
study populations (15–17). The very small number
of neoplasm cases found is, on the contrary, at
first sight, difficult to understand; this is probably
as a result of the fact that these patients also pre-
sented with a serious and complex clinical picture
with, apart from the LGF, alarm signals, which
warranted hospitalisation rather than outpatient
treatment.
In conclusion, the results of our study population
suggest: (i) that HH in LGF patients is an important
nosographical entity with a high prevalence, confirm-
ing the importance of diagnosing it by limiting the
diagnostic approach to a thorough physical examina-
tion and few but specific laboratory tests, and (ii)
that it is incorrect to make a clear and substantial
difference between the management of LGF and
FUO. In LGF, after the HH forms have been elimi-
nated, diagnostic work-up should not be different to
that of FUO because, in general, the causes of FUO
can also be responsible for LGF.
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